/People

Kevin M. Slawin

InvestorFounder

Managing Partner at Rapha Capital Management, LLC · Founder and CEO at Eos SENOLYTIX · Founder at FIZE Medical, Inc. · Founder at DELiver Therapeutics

Miami Beach, Florida

Writes $100K – $10M checks · typically $100K

FoundedDELiver TherapeuticsEos SENOLYTIXFIZE Medical, Inc.Perseus SENOLYTIXPhoenix SENOLYTIXPonce AuroraPrintBio

Find your path to Kevin

Sign up to see every warm intro you have to Kevin

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Kevin. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Founder and Managing Partner of Rapha Capital Management, an oncologic and robotic surgeon, biotech investor, and founder focused on oncology, T cells, and immunotherapy. He founded Bellicum Pharmaceuticals (NASDAQ: BLCM), which completed a successful IPO in 2014, and serves on the boards of several portfolio companies including 3DBio Therapeutics, FIZE Medical, Demeetra AgBio, and Imagin Medical.

Contact· self-published, not guessed

Founder and CEO at Eos SENOLYTIX

Intro paths

→

In turn, Kevin can intro founders to Eos SENOLYTIX's investors below.

Founder at FIZE Medical, Inc.

Intro paths

→

In turn, Kevin can intro founders to FIZE Medical, Inc.'s investors below.

Founder at DELiver Therapeutics

Intro paths

→

In turn, Kevin can intro founders to DELiver Therapeutics's investors below.

DELiver Therapeutics's investors · 1

Deals · 21

Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.

Frequently asked questions

Who is Kevin M. Slawin?
Founder and Managing Partner of Rapha Capital Management, an oncologic and robotic surgeon, biotech investor, and founder focused on oncology, T cells, and immunotherapy. He founded Bellicum Pharmaceuticals (NASDAQ: BLCM), which completed a successful IPO in 2014, and serves on the boards of several portfolio companies including 3DBio Therapeutics, FIZE Medical, Demeetra AgBio, and Imagin Medical.
Where does Kevin M. Slawin work?
Kevin M. Slawin is Founder of DELiver Therapeutics and Managing Partner at Rapha Capital Management, LLC and Founder and CEO at Eos SENOLYTIX and Founder at FIZE Medical, Inc..
What check size does Kevin M. Slawin write?
Kevin M. Slawin typically writes checks of $100K – $10M.
What companies did Kevin M. Slawin found?
Kevin M. Slawin founded DELiver Therapeutics, Eos SENOLYTIX, FIZE Medical, Inc., Perseus SENOLYTIX, Phoenix SENOLYTIX, Ponce Aurora, PrintBio.
What companies has Kevin M. Slawin invested in?
Investments tracked here include AsclepiX Therapeutics, Inc., FIZE Medical, Inc..

Founder mafias

About this profile. Compiled from public sources — Rapha Capital Management, LLC's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights